Skip Navigation LinksHome > May 2014 - Volume 21 - Issue 3 > Red cell adhesion in human diseases
Current Opinion in Hematology:
doi: 10.1097/MOH.0000000000000036
ERYTHROID SYSTEM AND ITS DISEASES: Edited by Narla Mohandas

Red cell adhesion in human diseases

Colin, Yvesa,b,c,d; Van Kim, Caroline Lea,b,c,d; El Nemer, Wassima,b,c,d

Erratum

Erratum

In the recent article by Colin et al.[1], Figure 5 contains a black and white microphotograph on the left and right sides of the figure that was obtained from a slide available in the authors’ lab and had previously been published by Wautier [2]. Permission and acknowledgement for this part of the figure should have been obtained and stated in the legend. The authors would like to apologise for this omission and thank Professor Wautier and his publisher, l’Harmattan, for their understanding and help in resolving this issue.

Current Opinion in Hematology. 21(4):369, July 2014.

Collapse Box

Abstract

Purpose of review

This review discusses the unexpected role of red blood cell (RBC) adhesiveness in the pathophysiology of two red cell diseases, hereditary spherocytosis and polycythemia vera, and two ‘nonerythroid’ disorders, central retinal vein occlusion and Gaucher disease. These pathologies share common clinical manifestations, that is vaso-occlusion and/or thrombotic events.

Recent findings

Recently, the direct involvement of RBC adhesion to the vascular endothelium has been demonstrated in the occurrence of vaso-occlusive events, in particular in sickle cell disease (SCD). Several erythroid adhesion molecules and their ligands have been identified that belong to different molecular classes (integrins, Ig-like molecules, lipids…) and are activated by a variety of signaling pathways. Among these, the laminin receptor, Lutheran/basal cell adhesion molecule, which is activated by phosphorylation, appears to play a central role in several pathologies.

Summary

RBC adhesiveness might be involved in complications such as the vaso-occlusive crisis in SCD, thrombosis in polycythemia vera, splenic sequestration in hereditary spherocytosis, occlusions in central retinal vein occlusion and bone infarcts in Gaucher disease. Characterization of this pathological process at the cellular and molecular levels should prove useful to develop new therapeutic approaches based on the blockade of RBC abnormal interactions with vascular endothelium and/or circulating blood cells.

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.